Cure, morbidity, and mortality associated with embolization of brain arteriovenous malformations: a review of 1246 patients in 32 series over a 35-year period

Neurosurgery. 1995 Dec;37(6):1031-9; discussion 1039-40. doi: 10.1227/00006123-199512000-00001.

Abstract

Published reports of cure, morbidity, and mortality associated with the embolization of 1246 brain arteriovenous malformations during the last 35 years were reviewed. Embolization resulted in cure in 5% of arteriovenous malformations. The cure rates of embolization were 4% in reports of 708 patients published before 1990 and 5% in reports of 538 patients published since 1990 (P = not significant). Temporary morbidity from embolization was 10%, and permanent morbidity was 8%. Permanent morbidity was 9% before 1990 and 8% since 1990 (P = not significant). Death after embolization of brain arteriovenous malformations occurred in 1% of patients. Mortality associated with the embolization was 2% before 1990 and 1% since 1990 (P = not significant). Long-term morbidity associated with the use of neurotoxic embolization materials is worrisome but has never been proven.

Publication types

  • Review

MeSH terms

  • Bucrylate / adverse effects
  • Cause of Death
  • Embolization, Therapeutic* / instrumentation
  • Embolization, Therapeutic* / mortality
  • Enbucrilate / adverse effects
  • Equipment Design
  • Humans
  • Intracranial Arteriovenous Malformations / mortality*
  • Intracranial Arteriovenous Malformations / therapy*
  • Polyvinyl Alcohol / adverse effects
  • Risk Factors
  • Survival Rate
  • Tissue Adhesives / adverse effects

Substances

  • Tissue Adhesives
  • Bucrylate
  • Polyvinyl Alcohol
  • Enbucrilate